Highbridge Capital Management’s Idexx Laboratories IDXX Stock Holding History

Highbridge Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,000	Closed	-$220K	–	670
2018 Q2	$220K	Buy	+1,000	New	+$206K	﹤0.01%	791
2018 Q1	–	Sell	-5,600	Closed	-$877K	–	1427
2017 Q4	$877K	Sell	5,600 -200	-3%	-$31.5K	0.02%	634
2017 Q3	$902K	Buy	+5,800	New	+$917K	0.01%	640

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Highbridge Capital Management's IDXX Position: Q4 2018 in Review

Highbridge Capital Management sold out of Idexx Laboratories (IDXX) in Q4 2018, closing a stake of 17,000 shares — an estimated $4.24M sold.

Highbridge Capital Management first reported a position in IDXX in Q4 2016 and held it in 4 quarters. The position peaked at $4.24M in Q3 2018. 671 funds tracked by Wall St. Rank hold IDXX as of Q4 2018.

Highbridge Capital Management reported no remaining Idexx Laboratories position as of Q4 2018 after selling out during the quarter.
Highbridge Capital Management sold 17,000 Idexx Laboratories shares in Q4 2018, an estimated $4.24M.
Highbridge Capital Management first reported a position in Idexx Laboratories in Q4 2016 and held it in 4 quarters.
Highbridge Capital Management's Idexx Laboratories position peaked at $4.24M in Q3 2018.
671 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.